Skip to main content
. 2017 Jun 30;8(46):80405–80415. doi: 10.18632/oncotarget.18903

Table 1. Distribution of patients and tissue characteristics.

Characteristics Female FKBP51 (x¯±S) P-value
Cases (n = 98) Controls (n = 97) Total (n = 195)
Age (y) < 0.0001
 11–20 - 3 3 0.03 ± 0.01
 21–30 - 25 25 0.06 ± 0.05
 31–40 7 23 30 0.06 ± 0.05
 41–50 14 26 40 0.04 ± 0.03
 51–60 49 18 67 0.02 ± 0.02
 61–70 21 2 23 0.02 ± 0.02
 71–80 7 - 7 0.01 ± 0.01
 Median (y) 56.5 (y) 38 (y) 50 (y)
 Mini-Maxi (y) 31–78 (y) 12–64 (y) 12–78 (y)
Histological grade 0.49
 I 34 - 34 0.02 ± 0.02
 II 46 - 46 0.02 ± 0.02
 III 18 - 18 0.02 ± 0.04
TNM stage 0.8
 I 90 - 90 0.02 ± 0.02
 II 5 - 5 0.02 ± 0.02
 III 3 - 3 0.01 ± 0.01
Menstrual cycle phase 0.0087
 Proliferative phase - 50 50 0.04 ± 0.03
 Secretory phase - 47 47 0.06 ± 0.05